Anklyosing Spondylitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anklyosing Spondylitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07503327

Effectiveness of Telerehabilitation in Ankylosing Spondylitis

Purpose of the study: Ankylosing spondylitis (AS) is a chronic disease that affects the spine and joints, causing pain, stiffness, fatigue, and reduced quality…

Turkey (Türkiye)66 participantsStarted 2025-08-01

Treatment: Synchronous Telerehabilitation Exercise Program, Asynchronous Telerehabilitation Exercise Program

All recent trials (3 shown)

CompletedNot Applicable

NCT07509463

CALLY Index and Disease Activity in Ankylosing Spondylitis

This retrospective cross-sectional observational study aims to evaluate the association between the C-reactive protein-albumin-lymphocyte (CALLY) index and dise…

Turkey (Türkiye)65 participantsStarted 2022-01-01

CompletedPhase 3

NCT01649375

16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosin…

This study assessed the efficacy and safety of secukinumab in patients with active ankylosing spondylitis who were tolerant to or had an inadequate response to…

United States219 participantsStarted 2012-10-18

Treatment: Secukinumab (75 mg), Placebo